181 related articles for article (PubMed ID: 25173560)
41. Evaluation of the bitterness of green tea catechins by a cell-based assay with the human bitter taste receptor hTAS2R39.
Narukawa M; Noga C; Ueno Y; Sato T; Misaka T; Watanabe T
Biochem Biophys Res Commun; 2011 Feb; 405(4):620-5. PubMed ID: 21272567
[TBL] [Abstract][Full Text] [Related]
42. Inhibitory effect of tea catechins on collagenase activity.
Makimura M; Hirasawa M; Kobayashi K; Indo J; Sakanaka S; Taguchi T; Otake S
J Periodontol; 1993 Jul; 64(7):630-6. PubMed ID: 8396176
[TBL] [Abstract][Full Text] [Related]
43. Effects of green tea extract and (-)-epigallocatechin-3-gallate on pharmacokinetics of nadolol in rats.
Misaka S; Miyazaki N; Fukushima T; Yamada S; Kimura J
Phytomedicine; 2013 Nov; 20(14):1247-50. PubMed ID: 23920278
[TBL] [Abstract][Full Text] [Related]
44. The galloyl moiety of green tea catechins is the critical structural feature to inhibit fatty-acid synthase.
Wang X; Song KS; Guo QX; Tian WX
Biochem Pharmacol; 2003 Nov; 66(10):2039-47. PubMed ID: 14599562
[TBL] [Abstract][Full Text] [Related]
45. Inhibitory Effects of (-)-Epigallocatechin-3-gallate on Esophageal Cancer.
Wang LX; Shi YL; Zhang LJ; Wang KR; Xiang LP; Cai ZY; Lu JL; Ye JH; Liang YR; Zheng XQ
Molecules; 2019 Mar; 24(5):. PubMed ID: 30857144
[TBL] [Abstract][Full Text] [Related]
46. Drug-delivery systems of green tea catechins for improved stability and bioavailability.
Rodrigues CF; Ascenção K; Silva FA; Sarmento B; Oliveira MB; Andrade JC
Curr Med Chem; 2013; 20(37):4744-57. PubMed ID: 23834175
[TBL] [Abstract][Full Text] [Related]
47. Redox chemistry of the molecular interactions between tea catechins and human serum proteins under simulated hyperglycemic conditions.
Özyurt H; Luna C; Estévez M
Food Funct; 2016 Mar; 7(3):1390-400. PubMed ID: 26839039
[TBL] [Abstract][Full Text] [Related]
48. Green tea catechins prevent low-density lipoprotein oxidation via their accumulation in low-density lipoprotein particles in humans.
Suzuki-Sugihara N; Kishimoto Y; Saita E; Taguchi C; Kobayashi M; Ichitani M; Ukawa Y; Sagesaka YM; Suzuki E; Kondo K
Nutr Res; 2016 Jan; 36(1):16-23. PubMed ID: 26773777
[TBL] [Abstract][Full Text] [Related]
49. The Influence of In Vivo Metabolic Modifications on ADMET Properties of Green Tea Catechins-In Silico Analysis.
Matić S; Jadrijević-Mladar Takač M; Barbarić M; Lučić B; Gall Trošelj K; Stepanić V
J Pharm Sci; 2018 Nov; 107(11):2957-2964. PubMed ID: 30077700
[TBL] [Abstract][Full Text] [Related]
50. Green tea catechins inhibit the cultured smooth muscle cell invasion through the basement barrier.
Maeda K; Kuzuya M; Cheng XW; Asai T; Kanda S; Tamaya-Mori N; Sasaki T; Shibata T; Iguchi A
Atherosclerosis; 2003 Jan; 166(1):23-30. PubMed ID: 12482547
[TBL] [Abstract][Full Text] [Related]
51. Human cancer stem cells are a target for cancer prevention using (-)-epigallocatechin gallate.
Fujiki H; Sueoka E; Rawangkan A; Suganuma M
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2401-2412. PubMed ID: 28942499
[TBL] [Abstract][Full Text] [Related]
52. Implications of Green Tea and Its Constituents in the Prevention of Cancer via the Modulation of Cell Signalling Pathway.
Rahmani AH; Al Shabrmi FM; Allemailem KS; Aly SM; Khan MA
Biomed Res Int; 2015; 2015():925640. PubMed ID: 25977926
[TBL] [Abstract][Full Text] [Related]
53. Glucuronides of tea catechins: enzymology of biosynthesis and biological activities.
Lu H; Meng X; Li C; Sang S; Patten C; Sheng S; Hong J; Bai N; Winnik B; Ho CT; Yang CS
Drug Metab Dispos; 2003 Apr; 31(4):452-61. PubMed ID: 12642472
[TBL] [Abstract][Full Text] [Related]
54. Complex effects of different green tea catechins on human platelets.
Lill G; Voit S; Schrör K; Weber AA
FEBS Lett; 2003 Jul; 546(2-3):265-70. PubMed ID: 12832052
[TBL] [Abstract][Full Text] [Related]
55. Interactions between milk fat globules and green tea catechins.
Rashidinejad A; Birch EJ; Everett DW
Food Chem; 2016 May; 199():347-55. PubMed ID: 26775981
[TBL] [Abstract][Full Text] [Related]
56. Potential role of green tea catechins in various disease therapies: progress and promise.
Mak JC
Clin Exp Pharmacol Physiol; 2012 Mar; 39(3):265-73. PubMed ID: 22229384
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of human liver catechol-O-methyltransferase by tea catechins and their metabolites: structure-activity relationship and molecular-modeling studies.
Chen D; Wang CY; Lambert JD; Ai N; Welsh WJ; Yang CS
Biochem Pharmacol; 2005 May; 69(10):1523-31. PubMed ID: 15857617
[TBL] [Abstract][Full Text] [Related]
58. Direct interaction of natural and synthetic catechins with signal transducer activator of transcription 1 affects both its phosphorylation and activity.
Menegazzi M; Mariotto S; Dal Bosco M; Darra E; Vaiana N; Shoji K; Safwat AA; Marechal JD; Perahia D; Suzuki H; Romeo S
FEBS J; 2014 Feb; 281(3):724-38. PubMed ID: 24255956
[TBL] [Abstract][Full Text] [Related]
59. Dietary gallate esters of tea catechins reduce deposition of visceral fat, hepatic triacylglycerol, and activities of hepatic enzymes related to fatty acid synthesis in rats.
Ikeda I; Hamamoto R; Uzu K; Imaizumi K; Nagao K; Yanagita T; Suzuki Y; Kobayashi M; Kakuda T
Biosci Biotechnol Biochem; 2005 May; 69(5):1049-53. PubMed ID: 15914933
[TBL] [Abstract][Full Text] [Related]
60. Metabolism of green tea catechins: an overview.
Feng WY
Curr Drug Metab; 2006 Oct; 7(7):755-809. PubMed ID: 17073579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
